PAICU Stock Price, News & Analysis

PAICU NASDAQ

Company Description

PAICU (NASDAQ: PAICU) is a publicly traded company.

PAICU stock has declined 2.5% over the past year.

This page provides a comprehensive overview of PAICU stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-2.54%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

PAICU (PAICU) stock. Over the past 12 months, the stock has lost 2.5%.

Latest News

View All

August 30, 2021

+1.71%

Revelation Biosciences, Inc., a Life Sciences Company Developing Therapeutics and Diagnostics for Respiratory Viral Infections, Including COVID-19, to Become Publicly Traded Through a Merger with Petra Acquisition, Inc.

acquisition covid-19

June 1, 2021

+0.48%

PETRA ACQUISITION, INC. RECEIVES EXPECTED NASDAQ NOTIFICATION REGARDING DELAYED FORM 10-Q

acquisition

PAICU has 2 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 0 with negative movement. Key topics include acquisition, covid-19. View all PAICU news →

SEC Filings

View All

No SEC filings available for PAICU.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months